Related Experiment Video
Updated: Jul 30, 2025

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
Published on: January 30, 2014
The Functions and Phenotypes of Microglia in Alzheimer's Disease
Risako Fujikawa1, Makoto Tsuda1,2
1Department of Molecular and System Pharmacology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
Abstract:
Alzheimer's disease (AD) is the most prevalent neurodegenerative disease worldwide, but therapeutic strategies to slow down AD pathology and symptoms have not yet been successful. While attention has been focused on neurodegeneration in AD pathogenesis, recent decades have provided evidence of the importance of microglia, and resident immune cells in the central nervous system. In addition, new technologies, including single-cell RNA sequencing, have revealed heterogeneous cell states of microglia in AD. In this review, we systematically summarize the microglial response to amyloid-β and tau tangles, and the risk factor genes expressed in microglia. Furthermore, we discuss the characteristics of protective microglia that appear during AD pathology and the relationship between AD and microglia-induced inflammation during chronic pain. Understanding the diverse roles of microglia will help identify new therapeutic strategies for AD.
Insights
Microglia, the brain's immune cells, play a crucial role in Alzheimer's disease (AD) pathology. Understanding their diverse states and functions is key to developing new AD therapies.
Area of Science:
- Neuroscience
- Immunology
- Genetics
Background:
- Alzheimer's disease (AD) is a leading cause of neurodegeneration globally, with limited therapeutic success.
- Microglia, the resident immune cells of the central nervous system, are increasingly recognized for their importance in AD.
- Recent advancements reveal diverse microglial cell states within AD.
Purpose of the Study:
- To systematically review microglial responses to key AD pathologies (amyloid-β and tau tangles).
- To examine microglial risk factor gene expression in AD.
- To discuss protective microglial phenotypes and their link to AD-associated inflammation and chronic pain.
Main Methods:
- Systematic review of scientific literature on microglia in Alzheimer's disease.
- Analysis of single-cell RNA sequencing data to identify heterogeneous microglial states.
- Integration of findings on amyloid-β, tau pathology, risk genes, and inflammation.
Main Results:
- Microglia exhibit heterogeneous responses to amyloid-β plaques and tau tangles.
- Specific risk factor genes are expressed by microglia in AD.
- Protective microglial states and their connection to inflammation in AD and chronic pain are identified.
Conclusions:
- Microglial heterogeneity is central to Alzheimer's disease pathogenesis.
- Targeting specific microglial states offers potential therapeutic avenues for AD.
- Further understanding of microglia-immune interactions is crucial for novel AD treatment strategies.
More Related Videos
10:40Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain
Published on: October 27, 2019
07:54Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility
Published on: April 13, 2017
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Glial Cells